About this journal

Expert Review of Molecular Diagnostics [ISSN 1473-7159]; [e-ISSN 1744-8352] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and original papers in molecular diagnostics. The journal covers the detection and monitoring of the molecular causes of disease that are being translated into ground-breaking diagnostic and prognostic technologies to be used in the clinical diagnostic setting.

Expert Review of Molecular Diagnostics provides a forum for reporting the critical advances being made in this ever-expanding field, as well as the major challenges ahead in their clinical implementation. The journal delivers this information in concise, at-a-glance article formats: invaluable to a time-constrained community.

Articles focus on the following key areas:

• Contemporary genetic and genomic technologies including deep sequencing and genome-wide association studies.
• Molecular tools for infectious disease testing and detection of multiple resistant bacteria.
• Latest discoveries in oncology diagnostics.
• Progress in non-invasive prenatal testing, including molecular markers and ethical considerations.
• 'Omic’ diagnostic technologies including: pharmacogenomic, epigenomic, proteomic and metabolomic technologies.
• Disease predisposition and inherited genetic diseases testing.
• Diagnostic tests for point-of-care settings and for resource-limited settings as well as progress in developing handheld devices for molecular diagnostic tests.
• Progress in developing handheld devices for molecular diagnostic tests.
• Biomarker development and usage to target patient groups for personalized medicine.
• Tools for molecular prognosis.
• Novel technologies and developments in molecular diagnostic techniques.
• Regulatory, ethical and payor perspectives in molecular diagnostics.
  
  

Each issue of Expert Review of Molecular Diagnostics contains:

• Reviews on current and emerging topics relating to molecular diagnostics.
• Editorials discussing contentious issues in the field.
• Diagnostic profiles featuring independent, expert evaluations of diagnostic tests.
• Original Research - manuscripts detailing clinical studies with a presentation of previously unpublished data.

Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections:

Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results;

Article Highlights – an executive summary of the author’s most critical points.

Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.

Reach an international clinical and medical audience alongside other key option leaders in your field by publishing with Expert Review of Molecular Diagnostics, part of the Expert Collection brand. 

Authors can publish gold open access in this journal and may choose to publish using our Accelerated Publication services.

For any pre-submission enquiries, please contact the Commissioning Editor.

Editor-in-Chief

Prof. Attila T Lorincz, Queen Mary University of London, London, UK

Associate Editors

Dr. William C S Cho, Queen Elizabeth Hospital, Yau Ma Tei, Hong Kong

Prof. Samir Hanash, Fred Hutchinson Cancer Research Center, Seattle, WA, USA

Prof. George Poste, Arizona State University, Tempe, AZ, USA

Prof. Jeffrey S Ross, Albany Medical College, Albany, NY, USA

Editorial Board Members

Prof. Pascal Borry, Katholieke Universiteit Leuven, Leuven, Belgium

Prof. George Calin, University of Texas: MD Anderson Cancer Center, Houston, TX, USA

Prof. Allen Chan, The Chinese University of Hong Kong, Hong Kong SAR, China

Prof. Liang Cheng, Brown University, Providence, RI, USA

Dr. Alessia Cimadamore, Polytechnic University of the Marche Region, Ancona, Italy

Prof. Ajay Goel, City of Hope Comprehensive Cancer Center, Duarte, CA, USA

Prof. Gary Hardiman, Queen's University Belfast, Belfast, UK

Dr. Jan Trøst Jørgensen, Dx-Rx Institute, Fredensborg, Denmark

Prof. Allan Klein, Cleveland Clinic, Cleveland, OH, USA

Prof. Gerald Kost, UC Davis, Sacremento, CA, USA

Prof. Lance Liotta, George Mason University, Fairfax County, VA, USA

Prof. Dennis Lo, The Chinese University of Hong Kong, Hong Kong, China

Prof. Matthew William McCarthy, Cornell University, Tompkins County, NY, USA

Prof. Joy Sarojini Michael, Christian Medical College, Vellore, India

Prof. Rodolfo Montironi, Polytechnic University of the Marche Region, Ancona, Italy

Prof. Shuji Ogino, Dana-Farber Cancer Institute, Boston, MA, USA

Prof. Stephen Povoski, Ohio State University, Columbus, OH, USA

Dr. Ken Pritzker, RNA Diagnostics Inc., Toronto, ON, Canada

Prof. Jean-Marc Rolain, Aix-Marseille Université, Marseille, France

Prof. Manuel Salto-Tellez, Queen’s University Belfast, Belfast, UK

Prof. Oliver Schildgen, Hospital of the Private University, Cologne, Germany

Prof. Jens Schittenhelm, Eberhard Karls University Tuebingen, Tuebingen, Germany

Prof. Jan Traeger-Synodinos, National and Kapodistrian University of Athens, Athens, Greece

Prof. Barbara Van Der Pol, University of Alabama at Birmingham School of Medicine, Birmingham, AL, USA

Prof. Tomasz Wojdacz, University of Aarhus, Aarhus, Denmark

News, offers and calls for papers

News and offers

• Discuss your submission with Commissioning Editor Edward Spofford: [email protected]